KLRD1 and neoplasm: Differential expression of exons 1 and 2 could specifically enhance HLA-E expression to resolve inflammation; over-expression of HLA-E has been previously reported in tumor cells in colorectal cancer and was associated with the inhibition of NK or CD94+/NKG2A+/CD8+ T cells infiltrating tumor tissue (46).